Sino-Implant (II): Quality Evaluation Report

The Sino-implant (II) Initiative has a rigorous quality assurance evaluation and monitoring program, implemented by FHI 360, to verify that Sino-implant (II) meets lot release specifications for the product. These reports expand on the results of the quality assurance evaluation and monitoring program conducted by year beginning in 2008.

File:

2016 Quality Assurance Report (148.3k)

2015 Quality Assurance Report (215.04k)

2014 Quality Assurance Report (98.06k)

2013 Quality Assurance Report (82.52k)

2012 Quality Assurance Report (78.37k)

2011 Quality Assurance Report (115.98k)

2010 Quality Assurance Report (127.07k)

2009 Quality Assurance Report (35.31k)

2008 Quality Assurance Report (44.48k)

Year:

2016

Organization:

FHI 360

Languages:

English

This website is made possible by the support of the American People through the United States Agency for International Development (USAID) under the Knowledge SUCCESS (Strengthening Use, Capacity, Collaboration, Exchange, Synthesis, and Sharing) Project. Knowledge SUCCESS is supported by USAID’s Bureau for Global Health, Office of Population and Reproductive Health and led by the Johns Hopkins Center for Communication Programs (CCP) in partnership with Amref Health Africa, The Busara Center for Behavioral Economics (Busara), and FHI 360. The contents of this website are the sole responsibility of CCP. The information provided on this website does not necessarily reflect the views of USAID, the United States Government, or the Johns Hopkins University. Read our full Security, Privacy, and Copyright Policies.